9-77794572-T-C
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM1PM2PP3_StrongPP5_Moderate
The NM_002072.5(GNAQ):c.626A>G(p.Gln209Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_002072.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GNAQ | NM_002072.5 | c.626A>G | p.Gln209Arg | missense_variant | Exon 5 of 7 | ENST00000286548.9 | NP_002063.2 | |
GNAQ | XM_047423239.1 | c.452A>G | p.Gln151Arg | missense_variant | Exon 5 of 7 | XP_047279195.1 | ||
GNAQ | XM_047423240.1 | c.452A>G | p.Gln151Arg | missense_variant | Exon 5 of 7 | XP_047279196.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 27
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Abnormal cardiovascular system morphology Pathogenic:1
- -
Sturge-Weber syndrome Pathogenic:1
A GNAQ c.626A>G (p.Gln209Arg) variant was identified at an allelic fraction consistent with somatic origin. The GNAQ c.626A>G (p.Gln209Arg) variant has been described in numerous patients affected with Sturge-Weber syndrome, choroidal hemangioma, non-syndromic capillary malformations, and cherry angiomas (Francis JH et al., PMID: 30537484; Le Guin CHD et al., PMID: 31336681; Galeffi F et al., PMID: 35635655; Klebanov N et al., PMID: 30601876). This variant has been reported in eleven cases in the cancer database COSMIC (Genomic Mutation ID: COSV54108414) and is absent from the general population (gnomAD v.3.1.2), indicating it is not a common variant. It lies within the GTP-binding site of the ras-like domain of GNAQ, which is defined as a critical functional domain (Markby DW et al., PMID: 8266082; Van Raamsdonk CD et al., PMID: 19078957). Computational predictors indicate that the GNAQ c.626A>G (p.Gln209Arg) variant is damaging, evidence that correlates with impact on GNAQ function. In support of this prediction, functional studies show increased activation of mitogen-activated protein kinase (MAPK) signaling pathways and associated downstream transcriptional programs in microvascular endothelial cells (Galeffi F et al., PMID: 35635655). The GNAQ gene is a gene that has a low rate of benign missense variation and where pathogenic missense variants are a common mechanism of disease. Other variants in the same codon, p.Gln209His, p.Gln209Leu and p.Gln209Pro, have been reported in multiple individuals and are considered pathogenic (Van Raamsdonk CD et al., PMID: 19078957; ClinVar IDs: 1172602, 1172601, 375955, 375957). Based on an internally-developed protocol informed by the ACMG/AMP guidelines (Richards S et al., PMID: 25741868), the GNAQ c.626A>G (p.Gln209Arg) variant is classified as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at